Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AMPAC Fine Chemicals To Be Acquired By SK Holdings 2018-07-16 08:00
ROHTO Exhibits Concept Models of Eye-drops for Four Extreme Conditions at Art Gallery in Daikanyama, Tokyo 2018-07-13 13:00
OrigiMed Collaborates with Illumina to Further Develop and Promote its Advanced Clinical Molecular Tumor Applications 2018-07-13 08:48
SK Holdings to Acquire AMPAC Fine Chemicals (AFC), a Leading Contract Development and Manufacturing Organization (CDMO) 2018-07-12 16:59
AGC to Expand GMP-Compliant Synthetic Pharmaceutical Intermediate and Active Ingredient Production Capacity Tenfold 2018-07-12 13:00
CStone's PD-1 inhibitor CS1003 receives clinical trial approval in China 2018-07-12 12:45
Aurigene Announces First in Human Dosing with RoRγt Inverse Agonist AUR-101 2018-07-12 03:37
Orig3n Expands Globally with Funding from Haitong International, International Tech Conference Partnerships 2018-07-12 03:29
Roche's New Timesaving Formulation of trastuzumab Approved in Indonesia for the Treatment of HER2-Positive Breast Cancer 2018-07-11 19:41
Lumitron Technologies, Inc. Creates Breakthrough Laser-Based, X-Ray Technologies 2018-07-11 11:41
Adlai Nortye Announce Global License Agreement for Buparlisib (BKM120) 2018-07-10 21:15
908 Devices and Hangzhou Just Biotherapeutics Announce Joint Innovation Partnership 2018-07-10 20:17
ACG Films & Foils Bags the SQMP Rating From Unilab Second Year in a Row 2018-07-10 15:41
Kiara Health's Vision to Transform Healthcare across Sub-Saharan Africa Applauded by Frost & Sullivan 2018-07-10 15:00
US FDA Approves Adagene IO Agonist IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 Trial 2018-07-10 08:08
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Rituximab Biosimilar 2018-07-10 01:30
Two new US patents further endorse ARANZ Medical's leadership in skin surface assessment technology 2018-07-09 22:00
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody 2018-07-09 22:00
Luzhou Talents Development Conference kicks off in China's Sichuan Province Fri. 2018-07-09 07:49
Frost & Sullivan Publishes Quarterly Update on BioLineRx Ltd.: Company is on track with its execution of multiple clinical development programs for the Company's lead product - BL-8040; the company has sufficient cash until H1-2020; target price remains unchanged 2018-07-06 23:41
1 701 702 703 704 705 970